Pomalyst (pomalidomide) — United Healthcare
Kaposi Sarcoma
Initial criteria
- Diagnosis of HIV-negative Kaposi Sarcoma
- OR
- Both of the following:
- Diagnosis of AIDS-related Kaposi Sarcoma
- AND
- Patient is currently being treated with antiretroviral therapy (ART)
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Pomalyst therapy
Approval duration
12 months